1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Brain Biomarker Revenue 1.4 Market Analysis by Type 1.4.1 Global Brain Biomarker Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Biomarker Test Kits 1.4.3 Biomarker Analyzers 1.5 Market by Application 1.5.1 Global Brain Biomarker Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Ambulatory Surgical Centers 1.5.4 Diagnostic Laboratories 1.6 Coronavirus Disease 2019 (Covid-19): Brain Biomarker Industry Impact 1.6.1 How the Covid-19 is Affecting the Brain Biomarker Industry 1.6.1.1 Brain Biomarker Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Brain Biomarker Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Brain Biomarker Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Brain Biomarker Market Perspective (2015-2026) 2.2 Brain Biomarker Growth Trends by Regions 2.2.1 Brain Biomarker Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Brain Biomarker Historic Market Share by Regions (2015-2020) 2.2.3 Brain Biomarker Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Brain Biomarker Market Growth Strategy 2.3.6 Primary Interviews with Key Brain Biomarker Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Brain Biomarker Players by Market Size 3.1.1 Global Top Brain Biomarker Players by Revenue (2015-2020) 3.1.2 Global Brain Biomarker Revenue Market Share by Players (2015-2020) 3.1.3 Global Brain Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Brain Biomarker Market Concentration Ratio 3.2.1 Global Brain Biomarker Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Brain Biomarker Revenue in 2019 3.3 Brain Biomarker Key Players Head office and Area Served 3.4 Key Players Brain Biomarker Product Solution and Service 3.5 Date of Enter into Brain Biomarker Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Brain Biomarker Historic Market Size by Type (2015-2020) 4.2 Global Brain Biomarker Forecasted Market Size by Type (2021-2026) 5 Brain Biomarker Breakdown Data by Application (2015-2026) 5.1 Global Brain Biomarker Market Size by Application (2015-2020) 5.2 Global Brain Biomarker Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Brain Biomarker Market Size (2015-2020) 6.2 Brain Biomarker Key Players in North America (2019-2020) 6.3 North America Brain Biomarker Market Size by Type (2015-2020) 6.4 North America Brain Biomarker Market Size by Application (2015-2020) 7 Europe 7.1 Europe Brain Biomarker Market Size (2015-2020) 7.2 Brain Biomarker Key Players in Europe (2019-2020) 7.3 Europe Brain Biomarker Market Size by Type (2015-2020) 7.4 Europe Brain Biomarker Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Brain Biomarker Market Size (2015-2020) 8.2 Brain Biomarker Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Brain Biomarker Market Size by Type (2015-2020) 8.4 Asia-Pacific Brain Biomarker Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Philips 9.1.1 Philips Company Details 9.1.2 Philips Business Overview and Its Total Revenue 9.1.3 Philips Brain Biomarker Introduction 9.1.4 Philips Revenue in Brain Biomarker Business (2015-2020)) 9.1.5 Philips Recent Development 9.2 Johnson & Johnson 9.2.1 Johnson & Johnson Company Details 9.2.2 Johnson & Johnson Business Overview and Its Total Revenue 9.2.3 Johnson & Johnson Brain Biomarker Introduction 9.2.4 Johnson & Johnson Revenue in Brain Biomarker Business (2015-2020) 9.2.5 Johnson & Johnson Recent Development 9.3 Roche 9.3.1 Roche Company Details 9.3.2 Roche Business Overview and Its Total Revenue 9.3.3 Roche Brain Biomarker Introduction 9.3.4 Roche Revenue in Brain Biomarker Business (2015-2020) 9.3.5 Roche Recent Development 9.4 Seimens 9.4.1 Seimens Company Details 9.4.2 Seimens Business Overview and Its Total Revenue 9.4.3 Seimens Brain Biomarker Introduction 9.4.4 Seimens Revenue in Brain Biomarker Business (2015-2020) 9.4.5 Seimens Recent Development 9.5 GE 9.5.1 GE Company Details 9.5.2 GE Business Overview and Its Total Revenue 9.5.3 GE Brain Biomarker Introduction 9.5.4 GE Revenue in Brain Biomarker Business (2015-2020) 9.5.5 GE Recent Development 9.6 NeuroVista 9.6.1 NeuroVista Company Details 9.6.2 NeuroVista Business Overview and Its Total Revenue 9.6.3 NeuroVista Brain Biomarker Introduction 9.6.4 NeuroVista Revenue in Brain Biomarker Business (2015-2020) 9.6.5 NeuroVista Recent Development 9.7 Qiagen 9.7.1 Qiagen Company Details 9.7.2 Qiagen Business Overview and Its Total Revenue 9.7.3 Qiagen Brain Biomarker Introduction 9.7.4 Qiagen Revenue in Brain Biomarker Business (2015-2020) 9.7.5 Qiagen Recent Development 9.8 Lifesign 9.8.1 Lifesign Company Details 9.8.2 Lifesign Business Overview and Its Total Revenue 9.8.3 Lifesign Brain Biomarker Introduction 9.8.4 Lifesign Revenue in Brain Biomarker Business (2015-2020) 9.8.5 Lifesign Recent Development 9.9 Natus 9.9.1 Natus Company Details 9.9.2 Natus Business Overview and Its Total Revenue 9.9.3 Natus Brain Biomarker Introduction 9.9.4 Natus Revenue in Brain Biomarker Business (2015-2020) 9.9.5 Natus Recent Development 9.10 BrainScope 9.10.1 BrainScope Company Details 9.10.2 BrainScope Business Overview and Its Total Revenue 9.10.3 BrainScope Brain Biomarker Introduction 9.10.4 BrainScope Revenue in Brain Biomarker Business (2015-2020) 9.10.5 BrainScope Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Brain Biomarker Key Market Segments Table 2. Key Players Covered: Ranking by Brain Biomarker Revenue Table 3. Ranking of Global Top Brain Biomarker Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Brain Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Biomarker Test Kits Table 6. Key Players of Biomarker Analyzers Table 7. COVID-19 Impact Global Market: (Four Brain Biomarker Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Brain Biomarker Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Brain Biomarker Players to Combat Covid-19 Impact Table 12. Global Brain Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Brain Biomarker Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Brain Biomarker Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Brain Biomarker Market Share by Regions (2015-2020) Table 16. Global Brain Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Brain Biomarker Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Brain Biomarker Market Growth Strategy Table 22. Main Points Interviewed from Key Brain Biomarker Players Table 23. Global Brain Biomarker Revenue by Players (2015-2020) (Million US$) Table 24. Global Brain Biomarker Market Share by Players (2015-2020) Table 25. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2019) Table 26. Global Brain Biomarker by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Brain Biomarker Product Solution and Service Table 29. Date of Enter into Brain Biomarker Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Brain Biomarker Market Size by Type (2015-2020) (Million US$) Table 32. Global Brain Biomarker Market Size Share by Type (2015-2020) Table 33. Global Brain Biomarker Revenue Market Share by Type (2021-2026) Table 34. Global Brain Biomarker Market Size Share by Application (2015-2020) Table 35. Global Brain Biomarker Market Size by Application (2015-2020) (Million US$) Table 36. Global Brain Biomarker Market Size Share by Application (2021-2026) Table 37. North America Key Players Brain Biomarker Revenue (2019-2020) (Million US$) Table 38. North America Key Players Brain Biomarker Market Share (2019-2020) Table 39. North America Brain Biomarker Market Size by Type (2015-2020) (Million US$) Table 40. North America Brain Biomarker Market Share by Type (2015-2020) Table 41. North America Brain Biomarker Market Size by Application (2015-2020) (Million US$) Table 42. North America Brain Biomarker Market Share by Application (2015-2020) Table 43. Europe Key Players Brain Biomarker Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Brain Biomarker Market Share (2019-2020) Table 45. Europe Brain Biomarker Market Size by Type (2015-2020) (Million US$) Table 46. Europe Brain Biomarker Market Share by Type (2015-2020) Table 47. Europe Brain Biomarker Market Size by Application (2015-2020) (Million US$) Table 48. Europe Brain Biomarker Market Share by Application (2015-2020) Table 49. Asia-Pacific Key Players Brain Biomarker Revenue (2019-2020) (Million US$) Table 50. Asia-Pacific Key Players Brain Biomarker Market Share (2019-2020) Table 51. Asia-Pacific Brain Biomarker Market Size by Type (2015-2020) (Million US$) Table 52. Asia-Pacific Brain Biomarker Market Share by Type (2015-2020) Table 53. Asia-Pacific Brain Biomarker Market Size by Application (2015-2020) (Million US$) Table 54. Asia-Pacific Brain Biomarker Market Share by Application (2015-2020) Table 55. Philips Company Details Table 56. Philips Business Overview Table 57. Philips Product Table 58. Philips Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 59. Philips Recent Development Table 60. Johnson & Johnson Company Details Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Product Table 63. Johnson & Johnson Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 64. Johnson & Johnson Recent Development Table 65. Roche Company Details Table 66. Roche Business Overview Table 67. Roche Product Table 68. Roche Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 69. Roche Recent Development Table 70. Seimens Company Details Table 71. Seimens Business Overview Table 72. Seimens Product Table 73. Seimens Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 74. Seimens Recent Development Table 75. GE Company Details Table 76. GE Business Overview Table 77. GE Product Table 78. GE Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 79. GE Recent Development Table 80. NeuroVista Company Details Table 81. NeuroVista Business Overview Table 82. NeuroVista Product Table 83. NeuroVista Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 84. NeuroVista Recent Development Table 85. Qiagen Company Details Table 86. Qiagen Business Overview Table 87. Qiagen Product Table 88. Qiagen Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 89. Qiagen Recent Development Table 90. Lifesign Business Overview Table 91. Lifesign Product Table 92. Lifesign Company Details Table 93. Lifesign Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 94. Lifesign Recent Development Table 95. Natus Company Details Table 96. Natus Business Overview Table 97. Natus Product Table 98. Natus Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 99. Natus Recent Development Table 100. BrainScope Company Details Table 101. BrainScope Business Overview Table 102. BrainScope Product Table 103. BrainScope Revenue in Brain Biomarker Business (2015-2020) (Million US$) Table 104. BrainScope Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Brain Biomarker Market Share by Type: 2020 VS 2026 Figure 2. Biomarker Test Kits Features Figure 3. Biomarker Analyzers Features Figure 4. Global Brain Biomarker Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Diagnostic Laboratories Case Studies Figure 8. Brain Biomarker Report Years Considered Figure 9. Global Brain Biomarker Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Brain Biomarker Market Share by Regions: 2020 VS 2026 Figure 11. Global Brain Biomarker Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Brain Biomarker Market Share by Players in 2019 Figure 14. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Brain Biomarker Revenue in 2019 Figure 16. North America Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Asia-Pacific Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Philips Total Revenue (US$ Million): 2019 Compared with 2018 Figure 20. Philips Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 21. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 22. Johnson & Johnson Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 23. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Roche Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 25. Seimens Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Seimens Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 27. GE Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. GE Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 29. NeuroVista Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. NeuroVista Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 31. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Qiagen Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 33. Lifesign Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Lifesign Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 35. Natus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Natus Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 37. BrainScope Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. BrainScope Revenue Growth Rate in Brain Biomarker Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

Philips Johnson & Johnson Roche Seimens GE NeuroVista Qiagen Lifesign Natus BrainScope